Description of Perianal Lesions in a Cohort of Crohn's Disease Patients
LAPCROHN
1 other identifier
observational
200
1 country
1
Brief Summary
The perianal lesions (LAP) specific for Crohn's disease have been reported in 1938, six years after the first cases of luminal disease. If phenotypic data of the latter are well documented today, those of perianal disease remain inadequately described. The reasons are numerous: understated symptoms by patients, elementary semiotics proctology ignored by practitioners, lack of validated classifications to track these violations and challenges to undertake clinical trials to high standard of proof in view of these variables, etc. ... Moreover, the impact of these LAP varies across studies (10-80%). in addition to the above-mentioned reasons, these results are also due to the different definitions of LAP used in the studies, their collection in reference centers versus tertiary centers, their potential occurrence at any time of disease progression, their greater frequency in case of distal disease (12% for infringement isolated ileal, 15% in breach ileo colic, 41% in case of colonic involvement and 91% in case of rectal involvement). Yet the specific LAP should be better documented because they are a factor of poor prognosis of Crohn's disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2015
CompletedFirst Submitted
Initial submission to the registry
September 8, 2016
CompletedFirst Posted
Study publicly available on registry
September 13, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedSeptember 8, 2017
September 1, 2017
1.4 years
September 8, 2016
September 5, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Assessment of PDAI Score
activity profile of specific LAP (PDAI score of Irvine)
Day 15
Secondary Outcomes (4)
Assessment of Wexner score
Day 15
Assessment of phenotypic profile of the luminal disease (classification of Montreal)
Day 15
Assessment of Harvey-Bradshaw Index
Day 15
Assessment of quality of life by GIQLI questionary
Day 15
Interventions
Observational study to describe Perianal Lesions in a Cohort of Crohn's Disease Patients.
Eligibility Criteria
Crohn's disease diagnosed patients, all confused phenotype
You may qualify if:
- Crohn's disease diagnosed, all confused phenotype
- Perianal reached whatever its phenotype (specific or non-Crohn's disease).
You may not qualify if:
- Refusal or inability of the patient to be eventually reached by telephone
- Psychiatric pathology and / or non-understanding of the French language making the collection of random data
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Groupe Hospitalier Paris Saint Joseph
Paris, Île-de-France Region, 75014, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 8, 2016
First Posted
September 13, 2016
Study Start
July 1, 2015
Primary Completion
December 1, 2016
Study Completion
December 1, 2016
Last Updated
September 8, 2017
Record last verified: 2017-09